Skip to content

Effect of Transcranial Direct Current Stimulation on Cognitive Impairment in Children with Brain Injury: An fNIRS Study

Effects of Transcranial Direct Current Stimulation on Motor and Cognitive Dysfunction in Children with Brain Injury

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121146
Enrollment
Unknown
Registered
2026-03-26
Start date
2025-10-10
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Traumatic Brain Injury (including Traumatic Brain Injury (TBI), Hypoxic-Ischemic Encephalopathy (HIE), Encephalitis, Stroke, etc.)

Interventions

tDCS Group:tDCS Group: Electrical stimulation with a current intensity of 1.0 mA is administered, 20 minutes per session, 5 days per week. tDCS Protocol: A CE/FDA-certified transcranial direct current
Sham Stimulation Group:Sham Stimulation Group: The sham stimulation mode of the device is used. An electrical current of 1.0 mA is delivered for 30 seconds at the beginning and end of the stimulation,

Sponsors

Shengjing Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Age range: Children aged 4-12 years old. 2. Cognitive impairment assessment: Mild to moderate cognitive impairment (Griffiths total Developmental Quotient [DQ] < 85) confirmed by a standardized cognitive assessment tool (Griffiths Developmental Scales). 3. Guardian's informed consent: Guardians must sign an informed consent form and voluntarily agree to their child's participation in the study.

Exclusion criteria

Exclusion criteria: 1. Comorbidity with other neurological diseases: Such as uncontrolled epilepsy, progressive neurodegenerative diseases. 2. Severe systemic diseases: Diseases that may affect treatment safety, including congenital heart disease, severe hepatic or renal insufficiency, and immunodeficiency diseases. 3. Contraindications to transcranial direct current stimulation (tDCS): Uncontrolled pneumothorax, active otitis media, severe emphysema or pulmonary infection, epilepsy, skull defects, etc. 4. Inability to cooperate with treatment: Presence of severe behavioral problems (e.g., aggressive behavior) or sensory impairments (e.g., blindness, deafness) that prevent completion of the treatment process. 5. Other special circumstances: Changes in treatment plans within the past 4 weeks, refusal of family members to cooperate with follow-up, or risk of incomplete data recording.

Design outcomes

Primary

MeasureTime frame
Changes in blood oxygen metabolism;Griffiths Developmental Scales Score;Wechsler Memory Scale (WMS) Score;BRIEF-P and BRIEF Score;WeeFIM Score;

Countries

China

Contacts

Public ContactXie Jiani

Shengjing Hospital of China Medical University

xiejiani29@163.com+86 189 4025 3844

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 4, 2026